Skip to main content
Advanced Technical IVT

Carboprost

Pronunciation: CAR-boh-prost

A synthetic prostaglandin F2α analog used to treat postpartum hemorrhage from uterine atony.

Full Definition

Carboprost tromethamine (Hemabate) is a synthetic prostaglandin F2α analog used as a second-line uterotonic agent for postpartum hemorrhage when oxytocin is ineffective. It causes powerful uterine contractions and vasoconstriction but has significant side effects that impact anesthetic management. These include bronchospasm (contraindicated in asthma), pulmonary vasoconstriction, systemic hypertension, and gastrointestinal effects like nausea, vomiting, and diarrhea. The medication can also cause hyperthermia and should be used cautiously in patients with cardiovascular disease. Typical dosing is 250 μg intramuscularly, which can be repeated every 15-90 minutes.

Usage

Usage note: Contraindicated in asthma and pulmonary disease; monitor for bronchospasm and cardiovascular effects.

In Context

  • "Carboprost 250 μg IM was administered for continued uterine atony despite adequate oxytocin." — Emergency medication administration
  • "The patient developed bronchospasm following carboprost injection, requiring bronchodilator therapy." — Adverse drug reaction report

Also known as

Hemabate 15-methyl PGF2α

Don't confuse with

methylergonovine misoprostol dinoprostone

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON